Hexagon Nutrition reported strong financial performance for FY26, with gross revenue reaching ₹382.6 crore, an 18% increase from FY25. The company also saw significant improvements in EBITDA and PAT, alongside margin expansion and a net cash-positive balance sheet.
Hexagon Nutrition Delivers Robust FY26 Performance
Revenue ₹382.6 crore; EBITDA ₹52.9 crore Reader Takeaway: Healthy growth and margin expansion achieved; monitor B2C focus and export performance. ## What just happened Hexagon Nutrition Ltd. has announced its financial results for the fiscal year 2026 (FY26), showcasing significant growth and improved profitability. The company reported a gross revenue of ₹382.6 crore, a notable 18% increase compared to ₹324.9 crore in FY25. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) rose by 31.9% to ₹52.9 crore in FY26 from ₹40.1 crore in FY25. Profit After Tax (PAT) saw a substantial jump of 56% to ₹37.9 crore in FY26, up from ₹24.3 crore in FY25. ## Why this matters These results indicate a strong operational performance and effective scaling of the business. The significant increase in revenue and profits, coupled with margin expansion, suggests improved efficiency and a growing market presence. A net cash-positive balance sheet with net debt at ₹(14.5) crore further strengthens the company's financial standing, reducing leverage risk. ## The backstory Hexagon Nutrition has been focusing on scaling its B2C product mix and enhancing manufacturing efficiency. The company also relies significantly on exports. Its performance in FY25 already showed a positive trend, which has been amplified in FY26. ## What changes now The company's ability to sustain this growth momentum, achieve its medium-term target of an EBITDA margin exceeding 15%, and grow its B2C segment will be key. Continued strong export performance is also crucial given its importance to the company's revenue. ## Risks to watch High dependence on exports presents a risk due to global economic fluctuations and trade policies. Achieving the ambitious EBITDA margin target requires continued focus on operational efficiencies and product mix. ## Peer comparison While specific peer financial data for FY26 is not yet available, Hexagon Nutrition's growth and margin expansion appear robust. The company operates in the specialized nutrition segment, including clinical and wellness products. ## Context metrics (time-bound) * **Gross Revenue:** ₹382.6 crore (FY26) vs ₹324.9 crore (FY25) * **EBITDA:** ₹52.9 crore (FY26) vs ₹40.1 crore (FY25) * **PAT:** ₹37.9 crore (FY26) vs ₹24.3 crore (FY25) * **EBITDA Margin:** 13.8% (FY26) vs 12.3% (FY25) * **PAT Margin:** 9.9% (FY26) vs 7.4% (FY25) * **Net Debt:** ₹(14.5) crore (FY26) * **ROCE:** 20.94% (FY26) ## What to track next Investors should closely monitor the company's progress towards its 15%+ EBITDA margin target, the growth and impact of its B2C product offerings, and its performance in international markets.
